Diagnamed HoldingsDGNMF +9.03% EV-to-FCF is -9.94 as of Jun. 30, 2026. The stock has 1 warning sign investors should review. Among 407 Healthcare Providers & Services companies, Diagnamed Holdings ranks worse than 245700% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Diagnamed Holdings's Enterprise Value is $4.36 Mil.
Diagnamed Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.44 Mil. Therefore, Diagnamed Holdings's EV-to-FCF for today is -9.94.
The historical rank and industry rank for Diagnamed Holdings's EV-to-FCF or its related term are showing as below:
DGNMF'
s EV-to-FCF Range Over the Past 10 Years
Min: -10.89 Med: 0 Max: 0
Current: -10.89
DGNMF's EV-to-FCF is ranked worse than 100% of 407
companies
in the Healthcare Providers & Services industry
Industry Median: 17.51
vs DGNMF: -10.89
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Diagnamed Holdings's PE Ratio (TTM) for today is calculated as:
Diagnamed Holdings's share price for today is $0.035.
Diagnamed Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.018.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Diagnamed Holdings EV-to-FCF Related Terms
Diagnamed Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Diagnamed Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Diagnamed Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnamed Holdings EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Diagnamed Holdings's EV-to-FCF falls into.
Diagnamed Holdings's current Enterprise Value is $4.36 Mil.
Diagnamed Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.44 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnamed Holdings (DGNMF) has a EV-to-FCF of -9.94 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Diagnamed Holdings and its competitors. According to the industry distribution chart, Diagnamed Holdings ranks #999999 out of 407 companies in the Healthcare Providers & Services industry.
Is Diagnamed Holdings' EV-to-FCF too high?
Diagnamed Holdings' current EV-to-FCF is -9.94. Based on the distribution chart, Diagnamed Holdings ranks #999999 out of 407 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Diagnamed Holdings' EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Diagnamed Holdings ranks #999999 out of 407 companies for EV-to-FCF. This places Diagnamed Holdings in the lower half of its industry. The industry median EV-to-FCF is 17.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.51, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Diagnamed Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnamed Holdings's current EV-to-FCF is -9.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnamed Holdings stock overvalued right now?
Diagnamed Holdings (DGNMF) has a current EV-to-FCF of -9.94. The current EV-to-FCF is -9.94. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Diagnamed Holdings (DGNMF), the current EV-to-FCF is -9.94 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DGNMF has been successfully added to your 